Sale!

CTSA Gene Galactosialidosis Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CTSA Gene Galactosialidosis Genetic Test is a sophisticated diagnostic procedure designed to identify mutations in the CTSA gene, which are associated with Galactosialidosis, a rare genetic disorder. This condition is characterized by a deficiency of the protective lysosomal enzyme, leading to the accumulation of certain substances in the body that can cause a range of health issues, including visual problems, kidney dysfunction, and neurological issues. The test involves analyzing the patient’s DNA to detect any genetic anomalies in the CTSA gene that might lead to the condition.

Priced at 4400 AED, the test is available at DNA Labs UAE, a leading facility renowned for its advanced genetic testing services. DNA Labs UAE employs cutting-edge technology and highly skilled professionals to ensure accurate and reliable test results. This genetic test is crucial for early diagnosis and management of Galactosialidosis, enabling healthcare providers to devise appropriate treatment and management plans for affected individuals.

Description

CTSA Gene Galactosialidosis Genetic Test

Test Name: CTSA Gene Galactosialidosis Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CTSA Gene Galactosialidosis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Galactosialidosis.

Test Details:

CTSA gene galactosialidosis NGS genetic test is a type of genetic test that analyzes the CTSA gene for mutations associated with galactosialidosis. Galactosialidosis is a rare genetic disorder characterized by the deficiency of the enzyme protective protein/cathepsin A (PPCA), which is encoded by the CTSA gene.

The NGS (Next-Generation Sequencing) technology used in this genetic test allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of genetic variations in the CTSA gene. This test can identify mutations or variants in the CTSA gene that may be responsible for galactosialidosis.

Galactosialidosis is an autosomal recessive disorder, meaning that both copies of the CTSA gene must have mutations for the disease to manifest. Genetic testing can help identify individuals who carry mutations in the CTSA gene and are at risk of passing the condition to their children.

The CTSA gene galactosialidosis NGS genetic test can be used for diagnostic purposes in individuals suspected of having galactosialidosis based on clinical symptoms. It can also be used for carrier testing in individuals with a family history of the condition or for prenatal testing in couples at risk of having a child with galactosialidosis.

Genetic counseling is an important component of this testing process, as it can help individuals understand the implications of their test results and make informed decisions about family planning or medical management.

Test Name	CTSA Gene Galactosialidosis Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CTSA Gene Galactosialidosis NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Galactosialidosis
Test Details	CTSA gene galactosialidosis NGS genetic test is a type of genetic test that analyzes the CTSA gene for mutations associated with galactosialidosis. Galactosialidosis is a rare genetic disorder characterized by the deficiency of the enzyme protective protein/cathepsin A (PPCA), which is encoded by the CTSA gene. The NGS (Next-Generation Sequencing) technology used in this genetic test allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of genetic variations in the CTSA gene. This test can identify mutations or variants in the CTSA gene that may be responsible for galactosialidosis. Galactosialidosis is an autosomal recessive disorder, meaning that both copies of the CTSA gene must have mutations for the disease to manifest. Genetic testing can help identify individuals who carry mutations in the CTSA gene and are at risk of passing the condition to their children. The CTSA gene galactosialidosis NGS genetic test can be used for diagnostic purposes in individuals suspected of having galactosialidosis based on clinical symptoms. It can also be used for carrier testing in individuals with a family history of the condition or for prenatal testing in couples at risk of having a child with galactosialidosis. Genetic counseling is an important component of this testing process, as it can help individuals understand the implications of their test results and make informed decisions about family planning or medical management.